COMMUNIQUÉS West-GlobeNewswire

OrthoPediatrics Corp. to Participate in the 45th Canaccord Genuity Annual Growth Conference
04/08/2025
WARSAW, Ind., Aug. 04, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced [...]
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
04/08/2025
FOSTER CITY, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product [...]
FibroGen to Report Second Quarter 2025 Financial Results
04/08/2025
SAN FRANCISCO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce second quarter 2025 financial results on Monday, August 11 after the markets close. FibroGen will also conduct a conference [...]
Inspire Medical Systems, Inc. Announces Second Quarter 2025 Financial Results and Updates 2025 Outlook
04/08/2025
MINNEAPOLIS, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the company), a medical technology company focused on the development and commercialization of innovative, minimally [...]
Ardelyx Reports Second Quarter 2025 Financial Results and Provides Business Update
04/08/2025
Company reports strong commercial performance in the second quarter, recording $97.7 million in total revenue, reflecting 33% growth year-over-year IBSRELA generated net sales revenue of $65.0 million; XPHOZAH generated [...]
Merus N.V. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/08/2025
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company,” “we” and “our”), an oncology company developing innovative, full-length multispecific [...]
Agios’ PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in Saudi Arabia
04/08/2025
First regulatory approval for PYRUKYND in thalassemia, evaluated under SFDA’s Breakthrough Medicines Program Agios partnered with NewBridge Pharmaceuticals, a regional specialty company focused on the Middle East and [...]
Syndax Reports Second Quarter 2025 Financial Results and Provides Business Update
04/08/2025
– $28.6 million of Revuforj ® (revumenib) net revenue, representing 43% growth over 1Q25 – – $36.2 million of Niktimvo™ (axatilimab-csfr) net revenue reported by Incyte in first full quarter of launch; $9.4 million in [...]
Dunham House to Partner with CrossMed Healthcare Staffing
04/08/2025
OMAHA, Neb., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Dunham House, a first-of-its-kind, transformational initiative for combat-wounded veterans in need of long-term residential-centered care for their wounds, will partner [...]
Media advisory: Shriners Hospitals for Children Canada Invites Media to its Annual Golf Tournament
04/08/2025
MONTREAL, Aug. 04, 2025 (GLOBE NEWSWIRE) -- What: Shriners Hospitals for Children Canada invites members of the media to attend a special photo and interview opportunity during its Annual Golf Tournament at Summerlea [...]
Avis aux médias: L’Hôpital Shriners pour enfants Canada invite les médias à son tournoi de golf annuel
04/08/2025
MONTRÉAL, 04 août 2025 (GLOBE NEWSWIRE) -- Quoi : L’Hôpital Shriners pour enfants Canada convie les représentants des médias à une occasion spéciale de photos et d’entrevues dans le cadre de son tournoi de golf annuel, [...]
PolTREG Doses First Patient in Phase II Trial for Pre-Symptomatic Type 1 Diabetes with PTG-007
04/08/2025
PolTREG Doses First Patient in Phase II Trial for Pre-Symptomatic Type 1 Diabetes with PTG-007 PTG-007, an autologous cell therapy will be administered to 150 high-risk children aged 3–18, including a placebo-controlled [...]
Biofrontera Inc. to Report Second Quarter FY 2025 Financial Results on August 13, 2025
04/08/2025
Woburn, MA, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc., (Nasdaq:BFRI) ("Biofrontera" or the "Company") , a biopharmaceutical company specializing in the commercialization of dermatological products, announces it [...]
L’Avenue Derm: The Blueprint for Seven-Day Dermatologic Care, Revolutionizing Skin Health and Aesthetics
04/08/2025
L’Avenue Derm debuts in Manhattan with a one-month waitlist, redefining holistic dermatologic care. Members receive 7-day access to top dermatologists, yoga, nutrition, and tailored aesthetic treatments—seamlessly [...]
CROSSJECT remains engaged during the summer break
04/08/2025
Press Release CROSSJECT remains engaged during the summer break Maintenance operations are being carried out at production sites. Regulatory and development activities are continuing actively. Dijon, France, August 4, [...]
CROSSJECT reste mobilisé pendant la coupure estivale
04/08/2025
Communiqué de Presse CROSSJECT reste mobilisé pendant la coupure estivale Les opérations de maintenance sont déployées sur les sites de production. Les activités réglementaires et de développement se poursuivent [...]
Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes
04/08/2025
Data Demonstrate that Sana’s Hypoimmune (HIP)-Modified Pancreatic Islet Cells, Transplanted with No Immunosuppression, Persist and Function Over Time in Patient with Type 1 Diabetes Study Establishes Ability to [...]
Mainz Biomed Announces Pricing of $3.0 Million Follow-On Offering of Ordinary Shares and Warrants
04/08/2025
BERKELEY, Calif. and MAINZ, Germany, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of [...]
Clynt Reddy Joins MATTER Board of Directors
04/08/2025
Minneapolis, MN, Aug. 04, 2025 (GLOBE NEWSWIRE) -- MATTER, a Minnesota-based global NGO, is pleased to announce the appointment of Clynt Reddy to its Board of Directors. Reddy currently serves as the Executive Pastor at [...]

Pages